{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:22:31Z","timestamp":1793388151816,"version":"4.5.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NextGenerationEU Italian Ministry of University and Research","award":["PRIN-PNRR2022 CARE P2022CXN7X CUP I53D23006920001"],"award-info":[{"award-number":["PRIN-PNRR2022 CARE P2022CXN7X CUP I53D23006920001"]}]},{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["Advanced Grant 2022"],"award-info":[{"award-number":["Advanced Grant 2022"]}],"id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007176","name":"Scuola Superiore Sant'Anna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007176","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The role of tryptophan metabolism has been recognized in a wide range of physiological and pathological processes but is still only partially understood. Growing evidence highlights the importance of maintaining tryptophan homeostasis throughout life, with its disruption now linked to various neuropsychiatric conditions spanning from early life to aging. While it is increasingly evident that alterations in tryptophan metabolism have significant implications for both neurodevelopmental and neurodegenerative disorders, research has predominantly focused on the latter, leaving neurodevelopmental aspects comparatively underexplored. This review provides a comprehensive overview of both preclinical and clinical studies, highlighting the intricate relationship between tryptophan metabolism and neurodevelopment. Particular focus is given to the kynurenine pathway and gut microbiota-derived indole production, two interconnected metabolic branches with profound effects on brain maturation, plasticity, and immune regulation. Finally, we examine the pathophysiological consequences of tryptophan dysregulation in neurodevelopmental disorders, including autism spectrum disorder, attention-deficit\/hyperactivity disorder, and Rett syndrome. We also discuss potential therapeutic strategies targeting tryptophan metabolism in these conditions.<\/jats:p>","DOI":"10.1007\/s12035-025-05437-9","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:10:16Z","timestamp":1763608216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Tryptophan Metabolism in Neurodevelopment and Its Implications For Neurodevelopmental Disorders"],"prefix":"10.1007","volume":"63","author":[{"given":"Maria Grazia","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Tognini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"5437_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-1-4684-5952-4_32","volume":"294","author":"JC Peters","year":"1991","unstructured":"Peters JC (1991) Tryptophan nutrition and metabolism: an overview. Adv Exp Med Biol 294:345\u2013358","journal-title":"Adv Exp Med Biol"},{"key":"5437_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10050930","volume":"10","author":"N Tennoune","year":"2022","unstructured":"Tennoune N, Andriamihaja M, Blachier F (2022) Production of indole and indole-related compounds by the intestinal microbiota and consequences for the host: the good, the bad, and the ugly. Microorganisms 10:930","journal-title":"Microorganisms"},{"key":"5437_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010151","volume":"15","author":"H Jiang","year":"2022","unstructured":"Jiang H, Chen C, Gao J (2022) Extensive summary of the important roles of indole propionic acid, a gut microbial metabolite in host health and disease. Nutrients 15:151","journal-title":"Nutrients"},{"key":"5437_CR4","doi-asserted-by":"publisher","first-page":"105403","DOI":"10.1016\/j.nbd.2021.105403","volume":"156","author":"MA Pappolla","year":"2021","unstructured":"Pappolla MA, Perry G, Fang X et al (2021) Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer\u2019s disease. Neurobiol Dis 156:105403","journal-title":"Neurobiol Dis"},{"key":"5437_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.ajpath.2018.01.011","volume":"188","author":"EE Alexeev","year":"2018","unstructured":"Alexeev EE, Lanis JM, Kao DJ et al (2018) Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor. Am J Pathol 188:1183\u20131194","journal-title":"Am J Pathol"},{"key":"5437_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355\u2013366","journal-title":"Annu Rev Med"},{"key":"5437_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27051680","volume":"27","author":"T Guzel","year":"2022","unstructured":"Guzel T, Mirowska-Guzel D (2022) The role of serotonin neurotransmission in gastrointestinal tract and pharmacotherapy. Molecules 27:1680","journal-title":"Molecules"},{"key":"5437_CR8","doi-asserted-by":"crossref","unstructured":"Klaessens S, Stroobant V, De Plaen E, Van den Eynde BJ (2022) Systemic tryptophan homeostasis. Front Mol Biosci 9:897929","DOI":"10.3389\/fmolb.2022.897929"},{"key":"5437_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13229-016-0109-5","volume":"7","author":"F Gevi","year":"2016","unstructured":"Gevi F, Zolla L, Gabriele S, Persico AM (2016) Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol Autism 7:47","journal-title":"Mol Autism"},{"key":"5437_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/NDT.S239763","volume":"16","author":"X Huang","year":"2020","unstructured":"Huang X, Ding W, Wu F et al (2020) Increased plasma kynurenic acid levels are associated with impaired attention\/vigilance and social cognition in patients with schizophrenia. Neuropsychiatr Dis Treat 16:263\u2013271","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5437_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","volume":"112","author":"S Erhardt","year":"2017","unstructured":"Erhardt S, Schwieler L, Imbeault S, Engberg G (2017) The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 112:297\u2013306","journal-title":"Neuropharmacology"},{"key":"5437_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","volume":"55","author":"E Gulaj","year":"2010","unstructured":"Gulaj E, Pawlak K, Bien B, Pawlak D (2010) Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Adv Med Sci 55:204\u2013211","journal-title":"Adv Med Sci"},{"key":"5437_CR13","doi-asserted-by":"publisher","first-page":"9484217","DOI":"10.1155\/2022\/9484217","volume":"2022","author":"Y Liang","year":"2022","unstructured":"Liang Y, Xie S, He Y et al (2022) Kynurenine pathway metabolites as biomarkers in Alzheimer\u2019s disease. Dis Markers 2022:9484217","journal-title":"Dis Markers"},{"key":"5437_CR14","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.3390\/ijms21239333","volume":"21","author":"N Lajk\u00f3","year":"2020","unstructured":"Lajk\u00f3 N, Kata D, Szab\u00f3 M et al (2020) Sensitivity of rodent microglia to kynurenines in models of epilepsy and inflammation in vivo and in vitro: microglia activation is inhibited by kynurenic acid and the synthetic analogue SZR104. Int J Mol Sci 21:9333","journal-title":"Int J Mol Sci"},{"key":"5437_CR15","doi-asserted-by":"publisher","first-page":"104280","DOI":"10.1016\/j.ebiom.2022.104280","volume":"84","author":"J Yan","year":"2022","unstructured":"Yan J, Kothur K, Innes EA et al (2022) Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: a biomarker of response to corticosteroids. EBioMedicine 84:104280","journal-title":"EBioMedicine"},{"key":"5437_CR16","first-page":"286","volume":"45","author":"BS Fernandes","year":"2023","unstructured":"Fernandes BS, Inam ME, Enduru N et al (2023) The kynurenine pathway in Alzheimer\u2019s disease: a meta-analysis of central and peripheral levels. Rev Bras Psiquiatr 45:286\u2013297","journal-title":"Rev Bras Psiquiatr"},{"key":"5437_CR17","doi-asserted-by":"publisher","first-page":"19392","DOI":"10.1016\/S0021-9258(19)77645-5","volume":"263","author":"KM Hargreaves","year":"1988","unstructured":"Hargreaves KM, Pardridge WM (1988) Neutral amino acid transport at the human blood-brain barrier. J Biol Chem 263:19392\u201319397","journal-title":"J Biol Chem"},{"key":"5437_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0098-2997(83)90005-5","volume":"6","author":"DA Bender","year":"1983","unstructured":"Bender DA (1983) Biochemistry of tryptophan in health and disease. Mol Aspects Med 6:101\u2013197","journal-title":"Mol Aspects Med"},{"key":"5437_CR19","doi-asserted-by":"publisher","unstructured":"Fuchs D, Schroecksnadel K, Neurauter G, Bellmann-Weiler R, Ledochowski M, Weiss G (2010) Quality of Life and Tryptophan Degradation. In: Preedy VR, Watson RR (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https:\/\/doi.org\/10.1007\/978-0-387-78665-0_119","DOI":"10.1007\/978-0-387-78665-0_119"},{"key":"5437_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","volume":"81","author":"JR Moffett","year":"2003","unstructured":"Moffett JR, Namboodiri MA (2003) Tryptophan and the immune response. Immunol Cell Biol 81:247\u2013265","journal-title":"Immunol Cell Biol"},{"key":"5437_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/nu8010056","volume":"8","author":"TA Jenkins","year":"2016","unstructured":"Jenkins TA, Nguyen JCD, Polglaze KE, Bertrand PP (2016) Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients 8:56","journal-title":"Nutrients"},{"key":"5437_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF et al (2019) Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov 18:379\u2013401","journal-title":"Nat Rev Drug Discov"},{"key":"5437_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1017\/S031716710001266X","volume":"39","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Azechi H, Board M (2012) Essential role of excessive tryptophan and its neurometabolites in fatigue. Can J Neurol Sci 39:40\u201347","journal-title":"Can J Neurol Sci"},{"key":"5437_CR24","doi-asserted-by":"publisher","first-page":"2236S","DOI":"10.3945\/jn.111.157065","volume":"142","author":"JD Fernstrom","year":"2012","unstructured":"Fernstrom JD (2012) Effects and side effects associated with the non-nutritional use of tryptophan by humans. J Nutr 142:2236S-2244S","journal-title":"J Nutr"},{"key":"5437_CR25","first-page":"533","volume":"13","author":"J Volpi-Abadie","year":"2013","unstructured":"Volpi-Abadie J, Kaye AM, Kaye AD (2013) Serotonin syndrome. Ochsner J 13:533\u2013540","journal-title":"Ochsner J"},{"key":"5437_CR26","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/s41467-025-57414-4","volume":"16","author":"P Sun","year":"2025","unstructured":"Sun P, Wang M, Chai X et al (2025) Disruption of tryptophan metabolism by high-fat diet-triggered maternal immune activation promotes social behavioral deficits in male mice. Nat Commun 16:2105","journal-title":"Nat Commun"},{"key":"5437_CR27","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1038\/s41467-024-50807-x","volume":"15","author":"M Chajadine","year":"2024","unstructured":"Chajadine M, Laurans L, Radecke T et al (2024) Harnessing intestinal tryptophan catabolism to relieve atherosclerosis in mice. Nat Commun 15:6390","journal-title":"Nat Commun"},{"key":"5437_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40168-023-01606-x","volume":"11","author":"P Sun","year":"2023","unstructured":"Sun P, Wang M, Liu Y-X et al (2023) High-fat diet-disturbed gut microbiota-colonocyte interactions contribute to dysregulating peripheral tryptophan-kynurenine metabolism. Microbiome 11:154","journal-title":"Microbiome"},{"key":"5437_CR29","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/gutjnl-2021-324053","volume":"71","author":"Q Qi","year":"2022","unstructured":"Qi Q, Li J, Yu B et al (2022) Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies. Gut 71:1095\u20131105","journal-title":"Gut"},{"key":"5437_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep46337","volume":"7","author":"VD de Mello","year":"2017","unstructured":"de Mello VD, Paananen J, Lindstr\u00f6m J et al (2017) Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Sci Rep 7:46337","journal-title":"Sci Rep"},{"key":"5437_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1053\/j.jrn.2020.11.008","volume":"31","author":"H-L Yang","year":"2021","unstructured":"Yang H-L, Feng P, Xu Y et al (2021) The role of dietary fiber supplementation in regulating uremic toxins in patients with chronic kidney disease: a meta-analysis of randomized controlled trials. J Ren Nutr 31:438\u2013447","journal-title":"J Ren Nutr"},{"key":"5437_CR32","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/s41564-024-01737-3","volume":"9","author":"AK Sinha","year":"2024","unstructured":"Sinha AK, Laursen MF, Brinck JE et al (2024) Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota. Nat Microbiol 9:1964\u20131978","journal-title":"Nat Microbiol"},{"key":"5437_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR (2018) Microbial tryptophan catabolites in health and disease. Nat Commun 9:1\u201310","journal-title":"Nat Commun"},{"key":"5437_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02113","volume":"10","author":"S Taleb","year":"2019","unstructured":"Taleb S (2019) Tryptophan dietary impacts gut barrier and metabolic diseases. Front Immunol 10:2113","journal-title":"Front Immunol"},{"key":"5437_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuropharm.2016.03.001","volume":"112","author":"FM Notarangelo","year":"2017","unstructured":"Notarangelo FM, Pocivavsek A (2017) Elevated kynurenine pathway metabolism during neurodevelopment: implications for brain and behavior. Neuropharmacology 112:275\u2013285","journal-title":"Neuropharmacology"},{"key":"5437_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1471-4159.2007.04556.x","volume":"102","author":"P Guidetti","year":"2007","unstructured":"Guidetti P, Amori L, Sapko MT et al (2007) Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem 102:103\u2013111","journal-title":"J Neurochem"},{"key":"5437_CR37","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/bph.12230","volume":"169","author":"TW Stone","year":"2013","unstructured":"Stone TW, Darlington LG (2013) The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders: kynurenines and CNS disorders. Br J Pharmacol 169:1211\u20131227","journal-title":"Br J Pharmacol"},{"key":"5437_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Smith DG, Smythe GA et al (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527:105\u2013112","journal-title":"Adv Exp Med Biol"},{"key":"5437_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","volume":"247","author":"MN Perkins","year":"1982","unstructured":"Perkins MN, Stone TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247:184\u2013187","journal-title":"Brain Res"},{"key":"5437_CR40","unstructured":"Esser C (2016) Suppression and regulation of immune responses: methods and protocols. Springer, New York, NY"},{"key":"5437_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","unstructured":"Guti\u00e9rrez-V\u00e1zquez C, Quintana FJ (2018) Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48:19\u201333","journal-title":"Immunity"},{"key":"5437_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1538\/expanim.16-0092","volume":"66","author":"K Kawajiri","year":"2017","unstructured":"Kawajiri K, Fujii-Kuriyama Y (2017) The aryl hydrocarbon receptor: a multifunctional chemical sensor for host defense and homeostatic maintenance. Exp Anim 66:75\u201389","journal-title":"Exp Anim"},{"key":"5437_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep12689","volume":"5","author":"TD Hubbard","year":"2015","unstructured":"Hubbard TD, Murray IA, Bisson WH et al (2015) Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci Rep 5:12689","journal-title":"Sci Rep"},{"key":"5437_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41423-020-00585-5","volume":"18","author":"A Barroso","year":"2021","unstructured":"Barroso A, Mahler JV, Fonseca-Castro PH, Quintana FJ (2021) The aryl hydrocarbon receptor and the gut-brain axis. Cell Mol Immunol 18:259\u2013268","journal-title":"Cell Mol Immunol"},{"key":"5437_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1433747","volume":"18","author":"L Coretti","year":"2024","unstructured":"Coretti L, Buommino E, Lembo F (2024) The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases. Front Cell Neurosci 18:1433747","journal-title":"Front Cell Neurosci"},{"key":"5437_CR46","doi-asserted-by":"publisher","first-page":"646909","DOI":"10.1155\/2014\/646909","volume":"2014","author":"J Reyes Ocampo","year":"2014","unstructured":"Reyes Ocampo J, Lugo Huitr\u00f3n R, Gonz\u00e1lez-Esquivel D et al (2014) Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxid Med Cell Longev 2014:646909","journal-title":"Oxid Med Cell Longev"},{"key":"5437_CR47","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/19490976.2020.1758008","volume":"11","author":"N Ma","year":"2020","unstructured":"Ma N, He T, Johnston LJ, Ma X (2020) Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling. Gut Microbes 11:1203\u20131219","journal-title":"Gut Microbes"},{"key":"5437_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41419-023-05616-3","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang N, Xu L et al (2023) Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia\/reperfusion injury. Cell Death Dis 14:92","journal-title":"Cell Death Dis"},{"key":"5437_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep26386","volume":"6","author":"E Kimura","year":"2016","unstructured":"Kimura E, Ding Y, Tohyama C (2016) AhR signaling activation disrupts migration and dendritic growth of olfactory interneurons in the developing mouse. Sci Rep 6:26386","journal-title":"Sci Rep"},{"key":"5437_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1032302","volume":"15","author":"NR Martin","year":"2022","unstructured":"Martin NR, Patel R, Kossack ME et al (2022) Proper modulation of AHR signaling is necessary for establishing neural connectivity and oligodendrocyte precursor cell development in the embryonic zebrafish brain. Front Mol Neurosci 15:1032302","journal-title":"Front Mol Neurosci"},{"key":"5437_CR51","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2021.07.006","volume":"27","author":"N Joisten","year":"2021","unstructured":"Joisten N, Ruas JL, Braidy N et al (2021) The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force? Trends Mol Med 27:946\u2013954","journal-title":"Trends Mol Med"},{"key":"5437_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081270","volume":"11","author":"X Huang","year":"2022","unstructured":"Huang X, Feng Z, Cheng H-W (2022) Perspective: gestational tryptophan fluctuation altering neuroembryogenesis and psychosocial development. Cells 11:1270","journal-title":"Cells"},{"key":"5437_CR53","doi-asserted-by":"crossref","unstructured":"Badawy AA-B (2015) Tryptophan metabolism, disposition and utilization in pregnancy. Biosci Rep 35:e00261","DOI":"10.1042\/BSR20150197"},{"key":"5437_CR54","doi-asserted-by":"publisher","first-page":"574034","DOI":"10.3389\/fcell.2020.574034","volume":"8","author":"R Karahoda","year":"2020","unstructured":"Karahoda R, Abad C, Horackova H et al (2020) Dynamics of tryptophan metabolic pathways in human placenta and placental-derived cells: effect of gestation age and trophoblast differentiation. Front Cell Dev Biol 8:574034","journal-title":"Front Cell Dev Biol"},{"key":"5437_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4137\/IJTR.S2129","volume":"2","author":"DM Richard","year":"2009","unstructured":"Richard DM, Dawes MA, Mathias CW et al (2009) L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int J Tryptophan Res 2:45\u201360","journal-title":"Int J Tryptophan Res"},{"key":"5437_CR56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/15622970701513764","volume":"10","author":"S Russo","year":"2009","unstructured":"Russo S, Kema IP, Bosker F et al (2009) Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications. World J Biol Psychiatry 10:258\u2013268","journal-title":"World J Biol Psychiatry"},{"key":"5437_CR57","doi-asserted-by":"publisher","first-page":"985378","DOI":"10.3389\/fimmu.2022.985378","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, Yu S, Long Y et al (2022) Tryptophan metabolism: mechanism-oriented therapy for neurological and psychiatric disorders. Front Immunol 13:985378","journal-title":"Front Immunol"},{"key":"5437_CR58","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","volume":"27","author":"P Celada","year":"2013","unstructured":"Celada P, Bortolozzi A, Artigas F (2013) Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. CNS Drugs 27:703\u2013716","journal-title":"CNS Drugs"},{"key":"5437_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071087","volume":"12","author":"Y Murakami","year":"2023","unstructured":"Murakami Y, Imamura Y, Kasahara Y et al (2023) Maternal inflammation with elevated kynurenine metabolites is related to the risk of abnormal brain development and behavioral changes in autism spectrum disorder. Cells 12:1087","journal-title":"Cells"},{"key":"5437_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010199","volume":"13","author":"K Cohen Kadosh","year":"2021","unstructured":"Cohen Kadosh K, Muhardi L, Parikh P et al (2021) Nutritional support of neurodevelopment and cognitive function in infants and young children-an update and novel insights. Nutrients 13:199","journal-title":"Nutrients"},{"key":"5437_CR61","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fimmu.2014.00230","volume":"5","author":"P Sedlmayr","year":"2014","unstructured":"Sedlmayr P, Blaschitz A, Stocker R (2014) The role of placental tryptophan catabolism. Front Immunol 5:230","journal-title":"Front Immunol"},{"key":"5437_CR62","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.biochi.2017.07.008","volume":"140","author":"L Laurent","year":"2017","unstructured":"Laurent L, Deroy K, St-Pierre J et al (2017) Human placenta expresses both peripheral and neuronal isoform of tryptophan hydroxylase. Biochimie 140:159\u2013165","journal-title":"Biochimie"},{"key":"5437_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.placenta.2017.02.013","volume":"52","author":"P Murthi","year":"2017","unstructured":"Murthi P, Wallace EM, Walker DW (2017) Altered placental tryptophan metabolic pathway in human fetal growth restriction. Placenta 52:62\u201370","journal-title":"Placenta"},{"key":"5437_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jnr.24603","volume":"99","author":"CS Rosenfeld","year":"2021","unstructured":"Rosenfeld CS (2021) The placenta-brain-axis. J Neurosci Res 99:271\u2013283","journal-title":"J Neurosci Res"},{"key":"5437_CR65","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/humrep\/deae046","volume":"39","author":"SKM van Zundert","year":"2024","unstructured":"van Zundert SKM, van Egmond NCM, van Rossem L et al (2024) First trimester maternal tryptophan metabolism and embryonic and fetal growth: the Rotterdam Periconceptional Cohort (Predict Study). Hum Reprod 39:912\u2013922","journal-title":"Hum Reprod"},{"key":"5437_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/IJTR.S12715","volume":"6","author":"A Tsuji","year":"2013","unstructured":"Tsuji A, Nakata C, Sano M et al (2013) L-tryptophan metabolism in pregnant mice fed a high L-tryptophan diet and the effect on maternal, placental, and fetal growth. Int J Tryptophan Res 6:21\u201333","journal-title":"Int J Tryptophan Res"},{"key":"5437_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071595","author":"K Xu","year":"2017","unstructured":"Xu K, Liu H, Bai M et al (2017) Redox properties of tryptophan metabolism and the concept of tryptophan use in pregnancy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18071595","journal-title":"Int J Mol Sci"},{"key":"5437_CR68","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","volume":"70","author":"S Okuda","year":"1998","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70:299\u2013307","journal-title":"J Neurochem"},{"key":"5437_CR69","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1159\/000526647","volume":"44","author":"CA Moura","year":"2022","unstructured":"Moura CA, Cagni FC, Costa LRF et al (2022) Maternal stress during pregnancy in mice induces sex-dependent behavioral alterations in offspring along with impaired serotonin and kynurenine pathways of tryptophan metabolism. Dev Neurosci 44:603\u2013614","journal-title":"Dev Neurosci"},{"key":"5437_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/cells12182224","author":"M Marszalek-Grabska","year":"2023","unstructured":"Marszalek-Grabska M, Gawel K, Kosheva N et al (2023) Developmental exposure to kynurenine affects zebrafish and rat behavior. Cells. https:\/\/doi.org\/10.3390\/cells12182224","journal-title":"Cells"},{"key":"5437_CR71","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.neuropharm.2011.01.009","volume":"62","author":"U Meyer","year":"2012","unstructured":"Meyer U, Feldon J (2012) To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62:1308\u20131321","journal-title":"Neuropharmacology"},{"key":"5437_CR72","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","volume":"29","author":"U Meyer","year":"2005","unstructured":"Meyer U, Feldon J, Schedlowski M, Yee BK (2005) Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29:913\u2013947","journal-title":"Neurosci Biobehav Rev"},{"key":"5437_CR73","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1523\/JNEUROSCI.2534-15.2016","volume":"36","author":"N Goeden","year":"2016","unstructured":"Goeden N, Velasquez J, Arnold KA et al (2016) Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain. J Neurosci 36:6041\u20136049","journal-title":"J Neurosci"},{"key":"5437_CR74","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/biolre\/ioad181","volume":"110","author":"C Abad","year":"2024","unstructured":"Abad C, Karahoda R, Orbisova A et al (2024) Pathological shifts in tryptophan metabolism in human term placenta exposed to LPS or poly I:C. Biol Reprod 110:722\u2013738","journal-title":"Biol Reprod"},{"key":"5437_CR75","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1093\/hmg\/ddab169","volume":"30","author":"R Karahoda","year":"2021","unstructured":"Karahoda R, Robles M, Marushka J et al (2021) Prenatal inflammation as a link between placental expression signature of tryptophan metabolism and preterm birth. Hum Mol Genet 30:2053\u20132067","journal-title":"Hum Mol Genet"},{"key":"5437_CR76","first-page":"297","volume":"27","author":"NM Frerichs","year":"2024","unstructured":"Frerichs NM, de Meij TGJ, Niemarkt HJ (2024) Microbiome and its impact on fetal and neonatal brain development: current opinion in pediatrics. Curr Opin Clin Nutr Metab Care 27:297\u2013303","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"5437_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030379","volume":"11","author":"I Bresesti","year":"2022","unstructured":"Bresesti I, Salvatore S, Valetti G et al (2022) The microbiota-gut axis in premature infants: physio-pathological implications. Cells 11:379","journal-title":"Cells"},{"key":"5437_CR78","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.immuni.2021.11.005","volume":"55","author":"E Kim","year":"2022","unstructured":"Kim E, Paik D, Ramirez RN et al (2022) Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4+ T cells. Immunity 55:145-158.e7","journal-title":"Immunity"},{"key":"5437_CR79","doi-asserted-by":"publisher","first-page":"113471","DOI":"10.1016\/j.bbr.2021.113471","volume":"414","author":"JD Galley","year":"2021","unstructured":"Galley JD, Chen HJ, Antonson AM, Gur TL (2021) Prenatal stress-induced disruptions in microbial and host tryptophan metabolism and transport. Behav Brain Res 414:113471","journal-title":"Behav Brain Res"},{"key":"5437_CR80","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2024.08.006","volume":"122","author":"JD Galley","year":"2024","unstructured":"Galley JD, King MK, Rajasekera TA et al (2024) Gestational administration of Bifidobacterium dentium results in intergenerational modulation of inflammatory, metabolic, and social behavior. Brain Behav Immun 122:44\u201357","journal-title":"Brain Behav Immun"},{"key":"5437_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/nu16121808","volume":"16","author":"KY Sugino","year":"2024","unstructured":"Sugino KY, Janssen RC, McMahan RH et al (2024) Vertical transfer of maternal gut microbes to offspring of Western diet-fed dams drives reduced levels of tryptophan metabolites and postnatal innate immune response. Nutrients 16:1808","journal-title":"Nutrients"},{"key":"5437_CR82","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1017\/S1461145709990253","volume":"13","author":"L Asp","year":"2010","unstructured":"Asp L, Holtze M, Powell SB et al (2010) Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-\/- mice. Int J Neuropsychopharmacol 13:475\u2013485","journal-title":"Int J Neuropsychopharmacol"},{"key":"5437_CR83","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1038\/s41598-020-60159-3","volume":"10","author":"D Ramirez Ortega","year":"2020","unstructured":"Ramirez Ortega D, Ovalle Rodr\u00edguez P, Pineda B et al (2020) Kynurenine pathway as a new target of cognitive impairment induced by lead toxicity during the lactation. Sci Rep 10:3184","journal-title":"Sci Rep"},{"key":"5437_CR84","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s12035-018-1161-2","volume":"56","author":"GZ R\u00e9us","year":"2019","unstructured":"R\u00e9us GZ, Silva RH, de Moura AB et al (2019) Early maternal deprivation induces microglial activation, alters glial fibrillary acidic protein immunoreactivity and indoleamine 2,3-dioxygenase during the development of offspring rats. Mol Neurobiol 56:1096\u20131108","journal-title":"Mol Neurobiol"},{"key":"5437_CR85","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1111\/j.1460-9568.2012.08064.x","volume":"35","author":"A Pocivavsek","year":"2012","unstructured":"Pocivavsek A, Wu H-Q, Elmer GI et al (2012) Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood. Eur J Neurosci 35:1605\u20131612","journal-title":"Eur J Neurosci"},{"key":"5437_CR86","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"TC Fung","year":"2017","unstructured":"Fung TC, Olson CA, Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20:145\u2013155","journal-title":"Nat Neurosci"},{"key":"5437_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF01262727","volume":"42","author":"IP Lapin","year":"1978","unstructured":"Lapin IP (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42:37\u201343","journal-title":"J Neural Transm"},{"key":"5437_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-4886(84)90001-3","volume":"84","author":"R Schwarcz","year":"1984","unstructured":"Schwarcz R, Brush GS, Foster AC, French ED (1984) Seizure activity and lesions after intrahippocampal quinolinic acid injection. Exp Neurol 84:1\u201317","journal-title":"Exp Neurol"},{"key":"5437_CR89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0006-8993(93)91612-V","volume":"619","author":"K Nakano","year":"1993","unstructured":"Nakano K, Takahashi S, Mizobuchi M et al (1993) High levels of quinolinic acid in brain of epilepsy-prone E1 mice. Brain Res 619:195\u2013198","journal-title":"Brain Res"},{"key":"5437_CR90","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/jpet.107.127266","volume":"324","author":"J Guo","year":"2008","unstructured":"Guo J, Williams DJ, Puhl HL 3rd, Ikeda SR (2008) Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons. J Pharmacol Exp Ther 324:342\u2013351","journal-title":"J Pharmacol Exp Ther"},{"key":"5437_CR91","doi-asserted-by":"publisher","first-page":"103833","DOI":"10.1016\/j.ebiom.2022.103833","volume":"76","author":"C Mu","year":"2022","unstructured":"Mu C, Choudhary A, Mayengbam S et al (2022) Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms. EBioMedicine 76:103833","journal-title":"EBioMedicine"},{"key":"5437_CR92","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/epi.17899","volume":"65","author":"A Hanin","year":"2024","unstructured":"Hanin A, Chollet C, Demeret S et al (2024) Metabolomic changes in adults with status epilepticus: a human case-control study. Epilepsia 65:929\u2013943","journal-title":"Epilepsia"},{"key":"5437_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/IJTR.S2097","volume":"2","author":"Y Chen","year":"2009","unstructured":"Chen Y, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:1\u201319","journal-title":"Int J Tryptophan Res"},{"key":"5437_CR94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.24171\/j.phrp.2024.0286","volume":"16","author":"A Issac","year":"2025","unstructured":"Issac A, Halemani K, Shetty A et al (2025) The global prevalence of autism spectrum disorder in children: a systematic review and meta-analysis. Osong Public Health Res Perspect 16:3\u201327","journal-title":"Osong Public Health Res Perspect"},{"key":"5437_CR95","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neubiorev.2020.07.042","volume":"118","author":"M Dobrosavljevic","year":"2020","unstructured":"Dobrosavljevic M, Solares C, Cortese S et al (2020) Prevalence of attention-deficit\/hyperactivity disorder in older adults: a systematic review and meta-analysis. Neurosci Biobehav Rev 118:282\u2013289","journal-title":"Neurosci Biobehav Rev"},{"key":"5437_CR96","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.rasd.2021.101759","volume":"83","author":"Y Rong","year":"2021","unstructured":"Rong Y, Yang C-J, Jin Y, Wang Y (2021) Prevalence of attention-deficit\/hyperactivity disorder in individuals with autism spectrum disorder: a meta-analysis. Res Autism Spectr Disord 83:101759","journal-title":"Res Autism Spectr Disord"},{"key":"5437_CR97","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuroscience.2025.01.031","volume":"569","author":"N Lewis","year":"2025","unstructured":"Lewis N, Villani A, Lagopoulos J (2025) Gut dysbiosis as a driver of neuroinflammation in attention-deficit\/hyperactivity disorder: a review of current evidence. Neuroscience 569:298\u2013321","journal-title":"Neuroscience"},{"key":"5437_CR98","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neuroscience.2018.01.060","volume":"374","author":"C Doenyas","year":"2018","unstructured":"Doenyas C (2018) Gut microbiota, inflammation, and probiotics on neural development in autism spectrum disorder. Neuroscience 374:271\u2013286","journal-title":"Neuroscience"},{"key":"5437_CR99","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","volume":"26","author":"C Onore","year":"2012","unstructured":"Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26:383\u2013392","journal-title":"Brain Behav Immun"},{"key":"5437_CR100","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41582-021-00530-8","volume":"17","author":"VX Han","year":"2021","unstructured":"Han VX, Patel S, Jones HF, Dale RC (2021) Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol 17:564\u2013579","journal-title":"Nat Rev Neurol"},{"key":"5437_CR101","doi-asserted-by":"publisher","first-page":"837424","DOI":"10.3389\/fpsyt.2022.837424","volume":"13","author":"C Hours","year":"2022","unstructured":"Hours C, Recasens C, Baleyte J-M (2022) ASD and ADHD comorbidity: what are we talking about? Front Psychiatry 13:837424","journal-title":"Front Psychiatry"},{"key":"5437_CR102","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1742-2094-8-71","volume":"8","author":"GA Mostafa","year":"2011","unstructured":"Mostafa GA, Al-Ayadhi LY (2011) A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation 8:71","journal-title":"J Neuroinflammation"},{"key":"5437_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113054","volume":"23","author":"JH Park","year":"2022","unstructured":"Park JH (2022) Potential inflammatory biomarker in patients with attention deficit hyperactivity disorder. Int J Mol Sci 23:13054","journal-title":"Int J Mol Sci"},{"key":"5437_CR104","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/aur.3044","volume":"16","author":"AF Almulla","year":"2023","unstructured":"Almulla AF, Thipakorn Y, Tunvirachaisakul C, Maes M (2023) The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis. Autism Res 16:2302\u20132315","journal-title":"Autism Res"},{"key":"5437_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2020.00007","volume":"14","author":"JL Neul","year":"2020","unstructured":"Neul JL, Skinner SA, Annese F et al (2020) Metabolic signatures differentiate Rett syndrome from unaffected siblings. Front Integr Neurosci 14:7","journal-title":"Front Integr Neurosci"},{"key":"5437_CR106","doi-asserted-by":"publisher","first-page":"487","DOI":"10.15537\/smj.2018.5.21751","volume":"39","author":"HA Abdulamir","year":"2018","unstructured":"Abdulamir HA, Abdul-Rasheed OF, Abdulghani EA (2018) Serotonin and serotonin transporter levels in autistic children. Saudi Med J 39:487\u2013494","journal-title":"Saudi Med J"},{"key":"5437_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01375","volume":"13","author":"B Chakraborti","year":"2020","unstructured":"Chakraborti B, Verma D, Guhathakurta S et al (2020) Gender-specific effect of 5-HT and 5-HIAA on threshold level of behavioral symptoms and sex-bias in prevalence of autism spectrum disorder. Front Neurosci 13:1375. https:\/\/doi.org\/10.3389\/fnins.2019.01375","journal-title":"Front Neurosci"},{"key":"5437_CR108","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/ibd\/izaa208","volume":"26","author":"CR Manzella","year":"2020","unstructured":"Manzella CR, Jayawardena D, Pagani W et al (2020) Serum serotonin differentiates between disease activity states in Crohn\u2019s patients. Inflamm Bowel Dis 26:1607\u20131618","journal-title":"Inflamm Bowel Dis"},{"key":"5437_CR109","doi-asserted-by":"publisher","first-page":"G207","DOI":"10.1152\/ajpgi.00488.2002","volume":"285","author":"DR Linden","year":"2003","unstructured":"Linden DR, Chen J-X, Gershon MD et al (2003) Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285:G207\u2013G216","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5437_CR110","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/jcag\/gwad020","volume":"7","author":"JA Grondin","year":"2024","unstructured":"Grondin JA, Khan WI (2024) Emerging roles of gut serotonin in regulation of immune response, microbiota composition and intestinal inflammation. J Can Assoc Gastroenterol 7:88\u201396","journal-title":"J Can Assoc Gastroenterol"},{"key":"5437_CR111","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-20-1043","volume":"9","author":"T Li","year":"2021","unstructured":"Li T, Fu B, Zhang X et al (2021) Overproduction of gastrointestinal 5-HT promotes colitis-associated colorectal cancer progression via enhancing NLRP3 inflammasome activation. Cancer Immunol Res 9:1008\u20131023","journal-title":"Cancer Immunol Res"},{"key":"5437_CR112","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000097202","volume":"2","author":"WA Banks","year":"1995","unstructured":"Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood-brain barrier. NeuroImmunoModulation 2:241\u2013248","journal-title":"NeuroImmunoModulation"},{"key":"5437_CR113","first-page":"133","volume":"63","author":"CM Blatteis","year":"1990","unstructured":"Blatteis CM (1990) Neuromodulative actions of cytokines. Yale J Biol Med 63:133\u2013146","journal-title":"Yale J Biol Med"},{"key":"5437_CR114","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jnr.490280213","volume":"28","author":"WF Hickey","year":"1991","unstructured":"Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28:254\u2013260","journal-title":"J Neurosci Res"},{"key":"5437_CR115","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0304-3940(93)90224-9","volume":"163","author":"WA Banks","year":"1993","unstructured":"Banks WA, Kastin AJ, Gutierrez EG (1993) Interleukin-1 alpha in blood has direct access to cortical brain cells. Neurosci Lett 163:41\u201344","journal-title":"Neurosci Lett"},{"key":"5437_CR116","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41232-024-00352-3","volume":"44","author":"M Izumi","year":"2024","unstructured":"Izumi M, Nakanishi Y, Kang S, Kumanogoh A (2024) Peripheral and central regulation of neuro-immune crosstalk. Inflamm Regen 44:41","journal-title":"Inflamm Regen"},{"key":"5437_CR117","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s40001-022-00838-1","volume":"27","author":"H Cao","year":"2022","unstructured":"Cao H, Tang J, Liu Q et al (2022) Autism-like behaviors regulated by the serotonin receptor 5-HT2B in the dorsal fan-shaped body neurons of Drosophila melanogaster. Eur J Med Res 27:203","journal-title":"Eur J Med Res"},{"key":"5437_CR118","doi-asserted-by":"publisher","first-page":"114168","DOI":"10.1016\/j.bbr.2022.114168","volume":"438","author":"EM Kondaurova","year":"2023","unstructured":"Kondaurova EM, Belokopytova II, Kulikova EA et al (2023) On the role of serotonin 5-HT1A receptor in autistic-like behavior: cross talk of 5-HT and BDNF systems. Behav Brain Res 438:114168","journal-title":"Behav Brain Res"},{"key":"5437_CR119","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1038\/s41598-021-86162-w","volume":"11","author":"AM Higazi","year":"2021","unstructured":"Higazi AM, Kamel HM, Abdel-Naeem EA et al (2021) Expression analysis of selected genes involved in tryptophan metabolic pathways in Egyptian children with autism spectrum disorder and learning disabilities. Sci Rep 11:6931","journal-title":"Sci Rep"},{"key":"5437_CR120","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2040-2392-4-16","volume":"4","author":"L Boccuto","year":"2013","unstructured":"Boccuto L, Chen C-F, Pittman AR et al (2013) Decreased tryptophan metabolism in patients with autism spectrum disorders. Mol Autism 4:16","journal-title":"Mol Autism"},{"key":"5437_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2013.00609","volume":"7","author":"B Zikopoulos","year":"2013","unstructured":"Zikopoulos B, Barbas H (2013) Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum Neurosci 7:609","journal-title":"Front Hum Neurosci"},{"key":"5437_CR122","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13229-020-00390-x","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X, Bautista J, Liu E, Zikopoulos B (2020) Imbalance of laminar-specific excitatory and inhibitory circuits of the orbitofrontal cortex in autism. Mol Autism 11:83","journal-title":"Mol Autism"},{"key":"5437_CR123","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jtcme.2022.03.001","volume":"13","author":"A Mehra","year":"2023","unstructured":"Mehra A, Arora G, Sahni G et al (2023) Gut microbiota and autism spectrum disorder: from pathogenesis to potential therapeutic perspectives. J Tradit Complement Med 13:135\u2013149","journal-title":"J Tradit Complement Med"},{"key":"5437_CR124","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP et al (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264\u2013276","journal-title":"Cell"},{"issue":"93","key":"5437_CR125","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj4775","volume":"9","author":"KZ Sanidad","year":"2024","unstructured":"Sanidad KZ, Rager SL, Carrow HC et al (2024) Gut bacteria-derived serotonin promotes immune tolerance in early life. Sci Immunol 9(93):eadj4775","journal-title":"Sci Immunol"},{"key":"5437_CR126","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ebiom.2017.09.020","volume":"24","author":"AV Golubeva","year":"2017","unstructured":"Golubeva AV, Joyce SA, Moloney G et al (2017) Microbiota-related changes in bile acid & tryptophan metabolism are associated with gastrointestinal dysfunction in a mouse model of autism. EBioMedicine 24:166\u2013178","journal-title":"EBioMedicine"},{"key":"5437_CR127","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","volume":"155","author":"EY Hsiao","year":"2013","unstructured":"Hsiao EY, McBride SW, Hsien S et al (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155:1451\u20131463","journal-title":"Cell"},{"key":"5437_CR128","first-page":"306","volume":"24","author":"A Flemming","year":"2024","unstructured":"Flemming A (2024) Bacterial serotonin induces Treg cells in neonates. Nat Rev Immunol 24:306","journal-title":"Nat Rev Immunol"},{"key":"5437_CR129","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3390\/ijms20092115","volume":"20","author":"P Srikantha","year":"2019","unstructured":"Srikantha P, Mohajeri MH (2019) The possible role of the microbiota-gut-brain-axis in autism spectrum disorder. Int J Mol Sci 20:2115","journal-title":"Int J Mol Sci"},{"key":"5437_CR130","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: Text revision. 4th edn. Washington DC. https:\/\/doi.org\/10.1176\/appi.books.9780890423349Tryptophan","DOI":"10.1176\/appi.books.9780890423349Tryptophan"},{"key":"5437_CR131","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2019.05.005","volume":"182","author":"GA Dunn","year":"2019","unstructured":"Dunn GA, Nigg JT, Sullivan EL (2019) Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol Biochem Behav 182:22\u201334","journal-title":"Pharmacol Biochem Behav"},{"key":"5437_CR132","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jad.2024.10.050","volume":"369","author":"J Du","year":"2025","unstructured":"Du J, Fang L, Dong K, Zhou Z (2025) Exploring the complex relationship between attention deficit hyperactivity disorder and the immune system: a bidirectional Mendelian randomization analysis. J Affect Disord 369:854\u2013860","journal-title":"J Affect Disord"},{"key":"5437_CR133","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.283.5400.397","volume":"283","author":"RR Gainetdinov","year":"1999","unstructured":"Gainetdinov RR, Wetsel WC, Jones SR et al (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397\u2013401","journal-title":"Science"},{"key":"5437_CR134","doi-asserted-by":"publisher","unstructured":"Uzbekov M (2018) Monoamines and kynurenine involvement in pathogenetic mechanisms of attention deficit hyperactivity disorder or hyperkinetic syndrome. Glob J Intellect Dev Disabil 5. https:\/\/doi.org\/10.19080\/gjidd.2018.05.555667","DOI":"10.19080\/gjidd.2018.05.555667"},{"key":"5437_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020583","author":"D Cavaleri","year":"2024","unstructured":"Cavaleri D, Crocamo C, Morello P et al (2024) The kynurenine pathway in attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis of blood concentrations of tryptophan and its catabolites. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13020583","journal-title":"J Clin Med"},{"key":"5437_CR136","doi-asserted-by":"publisher","first-page":"113770","DOI":"10.1016\/j.psychres.2021.113770","volume":"298","author":"E Sa\u011flam","year":"2021","unstructured":"Sa\u011flam E, Bilgi\u00e7 A, Abu\u015fo\u011flu S et al (2021) The role of tryptophan metabolic pathway in children with attention deficit hyperactivity disorder with and without comorbid oppositional defiant disorder and conduct disorder. Psychiatry Res 298:113770","journal-title":"Psychiatry Res"},{"key":"5437_CR137","doi-asserted-by":"publisher","first-page":"13182","DOI":"10.1038\/s41598-019-49781-y","volume":"9","author":"Y Murakami","year":"2019","unstructured":"Murakami Y, Imamura Y, Saito K et al (2019) Altered kynurenine pathway metabolites in a mouse model of human attention-deficit hyperactivity\/autism spectrum disorders: a potential new biological diagnostic marker. Sci Rep 9:13182","journal-title":"Sci Rep"},{"key":"5437_CR138","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12402-011-0062-2","volume":"3","author":"RD Oades","year":"2011","unstructured":"Oades RD (2011) An exploration of the associations of pregnancy and perinatal features with cytokines and tryptophan\/kynurenine metabolism in children with attention-deficit hyperactivity disorder (ADHD). Atten Defic Hyperact Disord 3:301\u2013318","journal-title":"Atten Defic Hyperact Disord"},{"key":"5437_CR139","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12993-015-0080-x","volume":"11","author":"TIM Aarsland","year":"2015","unstructured":"Aarsland TIM, Landaas ET, Hegvik T-A et al (2015) Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study. Behav Brain Funct 11:36","journal-title":"Behav Brain Funct"},{"key":"5437_CR140","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s40120-022-00392-2","volume":"11","author":"J Quintero","year":"2022","unstructured":"Quintero J, Guti\u00e9rrez-Casares JR, \u00c1lamo C (2022) Molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on ADHD neurobiology: a review. Neurol Ther 11:1489\u20131517","journal-title":"Neurol Ther"},{"key":"5437_CR141","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41380-023-02314-6","volume":"29","author":"S Qu","year":"2024","unstructured":"Qu S, Zhou X, Wang Z et al (2024) The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment. Mol Psychiatry 29:165\u2013185","journal-title":"Mol Psychiatry"},{"key":"5437_CR142","doi-asserted-by":"publisher","first-page":"114060","DOI":"10.1016\/j.psychres.2021.114060","volume":"303","author":"A Molina-Carballo","year":"2021","unstructured":"Molina-Carballo A, Cubero-Mill\u00e1n I, Fern\u00e1ndez-L\u00f3pez L et al (2021) Methylphenidate ameliorates the homeostatic balance between levels of kynurenines in ADHD children. Psychiatry Res 303:114060","journal-title":"Psychiatry Res"},{"key":"5437_CR143","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/cap.2019.0072","volume":"30","author":"L Fern\u00e1ndez-L\u00f3pez","year":"2020","unstructured":"Fern\u00e1ndez-L\u00f3pez L, Molina-Carballo A, Cubero-Mill\u00e1n I et al (2020) Indole tryptophan metabolism and cytokine S100B in children with attention-deficit\/hyperactivity disorder: daily fluctuations, responses to methylphenidate, and interrelationship with depressive symptomatology. J Child Adolesc Psychopharmacol 30:177\u2013188","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"5437_CR144","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1038\/s41598-025-87546-y","volume":"15","author":"N Boonchooduang","year":"2025","unstructured":"Boonchooduang N, Louthrenoo O, Likhitweerawong N et al (2025) Impact of psychostimulants on microbiota and short-chain fatty acids alterations in children with attention-deficit\/hyperactivity disorder. Sci Rep 15:3034","journal-title":"Sci Rep"},{"key":"5437_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080733","volume":"14","author":"J Aresti-Sanz","year":"2021","unstructured":"Aresti-Sanz J, Schwalbe M, Pereira RR et al (2021) Stability of methylphenidate under various pH conditions in the presence or absence of gut microbiota. Pharmaceuticals (Basel) 14:733","journal-title":"Pharmaceuticals (Basel)"},{"key":"5437_CR146","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.3390\/ijms20174160","volume":"20","author":"E Borghi","year":"2019","unstructured":"Borghi E, Vignoli A (2019) Rett syndrome and other neurodevelopmental disorders share common changes in gut microbial community: a descriptive review. Int J Mol Sci 20:4160","journal-title":"Int J Mol Sci"},{"key":"5437_CR147","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ajmg.1320250530","volume":"1","author":"P Riederer","year":"1986","unstructured":"Riederer P, Weiser M, Wichart I et al (1986) Preliminary brain autopsy findings in progredient Rett syndrome. Am J Med Genet Suppl 1:305\u2013315","journal-title":"Am J Med Genet Suppl"},{"key":"5437_CR148","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neuroscience.2010.07.010","volume":"170","author":"M Santos","year":"2010","unstructured":"Santos M, Summavielle T, Teixeira-Castro A et al (2010) Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome. Neuroscience 170:453\u2013467","journal-title":"Neuroscience"},{"key":"5437_CR149","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/jimd.12689","volume":"47","author":"S Illescas","year":"2024","unstructured":"Illescas S, Diaz-Osorio Y, Serradell A et al (2024) Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmission. J Inherit Metab Dis 47:551\u2013569","journal-title":"J Inherit Metab Dis"},{"key":"5437_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110862","volume":"206","author":"J Wu","year":"2024","unstructured":"Wu J, Hu Q, Rao X et al (2024) Gut microbiome and metabolic profiles of mouse model for MeCP2 duplication syndrome. Brain Res Bull 206:110862","journal-title":"Brain Res Bull"},{"key":"5437_CR151","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","volume":"122","author":"CA Opitz","year":"2020","unstructured":"Opitz CA, Somarribas Patterson LF, Mohapatra SR et al (2020) The therapeutic potential of targeting tryptophan catabolism in cancer. Br J Cancer 122:30\u201344","journal-title":"Br J Cancer"},{"key":"5437_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061885","volume":"12","author":"O Saidi","year":"2020","unstructured":"Saidi O, Rochette E, Dor\u00e9 \u00c9 et al (2020) Randomized double-blind controlled trial on the effect of proteins with different tryptophan\/large neutral amino acid ratios on sleep in adolescents: the PROTMORPHEUS study. Nutrients 12:1885","journal-title":"Nutrients"},{"key":"5437_CR153","doi-asserted-by":"publisher","first-page":"807271","DOI":"10.3389\/fimmu.2022.807271","volume":"13","author":"F Peyraud","year":"2022","unstructured":"Peyraud F, Guegan J-P, Bodet D et al (2022) Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives. Front Immunol 13:807271","journal-title":"Front Immunol"},{"key":"5437_CR154","doi-asserted-by":"publisher","first-page":"e000870","DOI":"10.1136\/jitc-2020-000870","volume":"8","author":"A Naing","year":"2020","unstructured":"Naing A, Eder JP, Piha-Paul SA et al (2020) Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors. J Immunother Cancer 8:e000870","journal-title":"J Immunother Cancer"},{"key":"5437_CR155","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2018.08.009","volume":"836","author":"IBC Carneiro","year":"2018","unstructured":"Carneiro IBC, Toscano AE, Lacerda DC et al (2018) L-tryptophan administration and increase in cerebral serotonin levels: systematic review. Eur J Pharmacol 836:129\u2013135","journal-title":"Eur J Pharmacol"},{"key":"5437_CR156","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijdevneu.2012.01.002","volume":"30","author":"GM Flores-Cruz","year":"2012","unstructured":"Flores-Cruz GM, Escobar A (2012) Reduction of serotonergic neurons in the dorsal raphe due to chronic prenatal administration of a tryptophan-free diet. Int J Dev Neurosci 30:63\u201367","journal-title":"Int J Dev Neurosci"},{"key":"5437_CR157","doi-asserted-by":"publisher","first-page":"2601S","DOI":"10.3945\/jn.115.228643","volume":"146","author":"JD Fernstrom","year":"2016","unstructured":"Fernstrom JD (2016) A perspective on the safety of supplemental tryptophan based on its metabolic fates. J Nutr 146:2601S-2608S","journal-title":"J Nutr"},{"key":"5437_CR158","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fphys.2014.00205","volume":"5","author":"AP Abdala","year":"2014","unstructured":"Abdala AP, Bissonnette JM, Newman-Tancredi A (2014) Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists. Front Physiol 5:205","journal-title":"Front Physiol"},{"key":"5437_CR159","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1017\/S1461145713000473","volume":"16","author":"C-C Wang","year":"2013","unstructured":"Wang C-C, Lin H-C, Chan Y-H et al (2013) 5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model. Int J Neuropsychopharmacol 16:2027\u20132039","journal-title":"Int J Neuropsychopharmacol"},{"issue":"45\u201353","key":"5437_CR160","first-page":"e1","volume":"170","author":"DC Chugani","year":"2016","unstructured":"Chugani DC, Chugani HT, Wiznitzer M et al (2016) Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: a randomized trial. J Pediatr 170(45\u201353):e1-4","journal-title":"J Pediatr"},{"key":"5437_CR161","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11689-020-09328-z","volume":"12","author":"J Flores Guti\u00e9rrez","year":"2020","unstructured":"Flores Guti\u00e9rrez J, De Felice C, Natali G et al (2020) Protective role of mirtazapine in adult female Mecp2+\/- mice and patients with Rett syndrome. J Neurodev Disord 12:26","journal-title":"J Neurodev Disord"},{"key":"5437_CR162","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/B978-0-444-64012-3.00024-1","volume":"165","author":"AM Persico","year":"2019","unstructured":"Persico AM, Ricciardello A, Cucinotta F (2019) The psychopharmacology of autism spectrum disorder and Rett syndrome. Handb Clin Neurol 165:391\u2013414","journal-title":"Handb Clin Neurol"},{"key":"5437_CR163","doi-asserted-by":"publisher","first-page":"108221","DOI":"10.1016\/j.neuropharm.2020.108221","volume":"176","author":"C Villani","year":"2020","unstructured":"Villani C, Sacchetti G, Carli M, Invernizzi RW (2020) Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin. Neuropharmacology 176:108221","journal-title":"Neuropharmacology"},{"key":"5437_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004677.pub3","author":"K Williams","year":"2013","unstructured":"Williams K, Brignell A, Randall M et al (2013) Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004677.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5437_CR165","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ebch.786","volume":"6","author":"AM Reiersen","year":"2011","unstructured":"Reiersen AM, Handen B (2011) Commentary on \u201cSelective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).\u201d Evid Based Child Health 6:1082\u20131085","journal-title":"Evid Based Child Health"},{"key":"5437_CR166","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/14728222.2019.1634691","volume":"23","author":"EA Kulikova","year":"2019","unstructured":"Kulikova EA, Kulikov AV (2019) Tryptophan hydroxylase 2 as a therapeutic target for psychiatric disorders: focus on animal models. Expert Opin Ther Targets 23:655\u2013667","journal-title":"Expert Opin Ther Targets"},{"key":"5437_CR167","doi-asserted-by":"publisher","first-page":"907437","DOI":"10.3389\/fphar.2022.907437","volume":"13","author":"K Zhu","year":"2022","unstructured":"Zhu K, Liu C, Gao Y et al (2022) Cryo-EM structure and activator screening of human tryptophan hydroxylase 2. Front Pharmacol 13:907437","journal-title":"Front Pharmacol"},{"key":"5437_CR168","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nm.4335","volume":"23","author":"I Gantois","year":"2017","unstructured":"Gantois I, Khoutorsky A, Popic J et al (2017) Metformin ameliorates core deficits in a mouse model of fragile X syndrome. Nat Med 23:674\u2013677","journal-title":"Nat Med"},{"key":"5437_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00290","volume":"12","author":"L Wang","year":"2018","unstructured":"Wang L, Cai Y, Fan X (2018) Metformin administration during early postnatal life rescues autistic-like behaviors in the BTBR T+ Itpr3tf\/J mouse model of autism. Front Behav Neurosci 12:290","journal-title":"Front Behav Neurosci"},{"key":"5437_CR170","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainresbull.2022.02.021","volume":"183","author":"W Deng","year":"2022","unstructured":"Deng W, Li F, Ke H et al (2022) Effect of metformin in autistic BTBR T + Itpr3tf\/J mice administered a high-fat diet. Brain Res Bull 183:172\u2013183","journal-title":"Brain Res Bull"},{"key":"5437_CR171","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bbi.2024.09.014","volume":"123","author":"X Xie","year":"2025","unstructured":"Xie X, Li W, Xiong Z et al (2025) Metformin reprograms tryptophan metabolism via gut microbiome-derived bile acid metabolites to ameliorate depression-like behaviors in mice. Brain Behav Immun 123:442\u2013455","journal-title":"Brain Behav Immun"},{"key":"5437_CR172","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/advances\/nmy031","volume":"9","author":"R Patusco","year":"2018","unstructured":"Patusco R, Ziegler J (2018) Role of probiotics in managing gastrointestinal dysfunction in children with autism spectrum disorder: an update for practitioners. Adv Nutr 9:637\u2013650","journal-title":"Adv Nutr"},{"key":"5437_CR173","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.lfs.2017.12.027","volume":"194","author":"Y Yang","year":"2018","unstructured":"Yang Y, Tian J, Yang B (2018) Targeting gut microbiome: a novel and potential therapy for autism. Life Sci 194:111\u2013119","journal-title":"Life Sci"},{"key":"5437_CR174","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1039\/D0FO02375B","volume":"12","author":"Q Kong","year":"2021","unstructured":"Kong Q, Wang B, Tian P et al (2021) Daily intake of Lactobacillus alleviates autistic-like behaviors by ameliorating the 5-hydroxytryptamine metabolic disorder in VPA-treated rats during weaning and sexual maturation. Food Funct 12:2591\u20132604","journal-title":"Food Funct"},{"key":"5437_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/nu14081615","volume":"14","author":"Q Kong","year":"2022","unstructured":"Kong Q, Chen Q, Mao X et al (2022) Bifidobacterium longum CCFM1077 ameliorated neurotransmitter disorder and neuroinflammation closely linked to regulation in the kynurenine pathway of autistic-like rats. Nutrients 14:1615","journal-title":"Nutrients"},{"key":"5437_CR176","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","volume":"42","author":"M Modoux","year":"2021","unstructured":"Modoux M, Rolhion N, Mani S, Sokol H (2021) Tryptophan metabolism as a pharmacological target. Trends Pharmacol Sci 42:60\u201373","journal-title":"Trends Pharmacol Sci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05437-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:15:24Z","timestamp":1763615724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05437-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":176,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5437"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05437-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"97"}}